Luminal primary muscle-invasive bladder cancer patients are less likely to benefit from platinum-based neoadjuvant chemotherapy

被引：0

作者：

Boormans, J. L. ^{[1
]}

De Jong, J. J. ^{[1
]}

Liu, V. Y. T. ^{[2
]}

Bismar, T. A. ^{[3
]}

Boorjian, S. A. ^{[4
]}

Huang, H-C. ^{[2
]}

Davicioni, E. ^{[5
]}

Mian, O. Y. ^{[6
]}

Wright, J. L. ^{[7
]}

Necchi, A. ^{[8
]}

Dall'Era, M. ^{[9
]}

Kaimakliotis, H. Z. ^{[10
]}

Black, P. C. ^{[11
]}

Gibb, E. A. ^{[2
]}

Lotan, Y. ^{[12
]}

机构：

[1] Erasmus MC, Dept Urol, Rotterdam, Netherlands

[2] Decipher Biosci, Dept Res, Vancouver, BC, Canada

[3] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada

[4] Mayo Clin, Dept Urol, Rochester, MN USA

[5] Decipher Biosci, Dept Res, San Diego, CA USA

[6] Cleveland Clin, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA

[7] Univ Washington, Dept Urol, Seattle, WA 98195 USA

[8] Univ Vita Salute San Raffaele, Dept Med, Milan, Italy

[9] Univ Calif Davis, Dept Urol Surg, Davis, CA 95616 USA

[10] Indiana Univ, Dept Urol, Indianapolis, IN 46204 USA

[11] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada

[12] Univ Texas Southwestern, Dept Urol, Dallas, TX USA

来源：

EUROPEAN UROLOGY | 2021年 / 79卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

P0830

引用

页码：S1156 / S1156

页数：1

共 50 条

[21] NEOADJUVANT CHEMOTHERAPY RESULTS IN SKELETAL MUSCLE INDEX DECLINE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
Steinsiek, Nikki
Acevedo, Ann Martinez
Guimaraes, Alexander
Achim, Virginie
Jones, Paul
Bash, Jasper
Whitaker, Makena
Amling, Christopher L.
Cetnar, Jeremy
Liu, Jen-Jane
JOURNAL OF UROLOGY, 2018, 199 (04): : E531 - E531
[22] Potential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based chemotherapy in muscle-invasive bladder cancer (MIBC) patients
Font, A.
Domenech, M.
Ramirez, J. L.
Gago, J.
Carrato, C.
Cadenas, B.
Benitez, R.
Lobato, T.
Pineda, S.
Ruiz de Porras, V.
Calle, M. L.
Malats, N.
Real, F. X.
ANNALS OF ONCOLOGY, 2019, 30
[23] Potential role of a clinical, taxonomical classification and RNA expression integrated signature to predict response to neoadjuvant platinum-based chemotherapy in Muscle-Invasive Bladder Cancer (MIBC) patients
Gago, Ramos J. L.
Font, A.
Domenech, M.
Carrato, C.
Ramirez, J. L.
Cadenas, B.
Calle, M.
Malats, N.
Real, F. X.
EUROPEAN UROLOGY, 2021, 79 : S634 - S634
[24] Cost-effectiveness analysis of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer
Stevenson, Scott M.
Deibert, Chris M.
McKiernan, James M.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
[25] ETIOLOGY OF TREATMENT DELAYS IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR MUSCLE-INVASIVE BLADDER CANCER
El-Arabi, Ahmad
Sherman, Garth
Holzbeierlein, Jeffrey
Lee, Eugene
Wulff-Burchfield, Elizabeth
JOURNAL OF UROLOGY, 2019, 201 (04): : E1025 - E1026
[26] Etiology of Treatment Delays in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
El-Arabi, Ahmad M.
Alam, Syed M.
Sherman, Garth
Parker, William P.
Thompson, Jeffrey
Holzbeierlein, Jeffrey M.
Lee, Eugene K.
Wulff-Burchfield, Elizabeth M.
BLADDER CANCER, 2020, 6 (04) : 435 - 444
[27] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
Yafi, Faysal A.
Kassouf, Wassim
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
[28] Safety of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer and malignant ureteric obstruction
Strother, Marshall C.
Kutikov, Alexander
Epstein, Matthew
Bochner, Emily
Deng, Mengying
Handorf, Elizabeth
Lewis, Bianca
Ghatalia, Pooja
Greenberg, Richard E.
Chen, David
Viterbo, Rosalia
Anari, Fern
Smaldone, Marc C.
Zibelman, Matthew R.
Uzzo, Robert G.
Plimack, Elizabeth R.
Geynisman, Daniel M.
BJU INTERNATIONAL, 2022, 129 (03) : 364 - 372
[29] Neoadjuvant chemotherapy is not (yet) standard treatment for muscle-invasive bladder cancer
Sternberg, CN
Parmar, MKB
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (18) : 21S - 27S
[30] Neoadjuvant chemotherapy for muscle-invasive bladder cancer: A new standard of care?
Harland, S
BJU INTERNATIONAL, 2003, 92 (09) : 877 - 878

← 1 2 3 4 5 →